China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 224 full-time employees. The company went IPO on 2000-02-15. The firm's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The firm manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.
CPHI stock price ended at $1.28 on 星期一, after rising 3.23%
On the latest trading day Jan 26, 2026, the stock price of CPHI rose by 3.23%, climbing from $1.25 to $1.28. Throughout the session, the stock experienced a volatility of 3.20%, with prices fluctuating between a daily low of $1.25 and a high of $1.29. Alongside this price increase, trading volume also rose by 1.5K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 4.6K shares were traded, amounting to a market value of approximately $6.4M.